Frank X. Leonard, EVP, President, Novocure Oncology at NovoCure Ltd (NVCR), sold 28,083 shares at $19.92 ($552K) on 2025-02-27, disclosed to the SEC on 2025-03-03.
Seasonal sale ($552k) by EVP, President, Novocure Oncology — this insider has traded NVCR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.92 | 10,277 | $205K | 37.1% |
| 2 | $19.92 | 10,277 | $205K | 37.1% |
| 3 | $20.55 | 1,989 | $41K | 7.4% |
| 4 | $18.28 | 2,770 | $51K | 9.2% |
| 5 | $18.28 | 2,770 | $51K | 9.2% |
| Total | $19.64 avg | 28,083 |
| $552K |
| 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |